acetylleucyl-leucyl-norleucinal has been researched along with pepstatin in 2 studies
| Studies (acetylleucyl-leucyl-norleucinal) | Trials (acetylleucyl-leucyl-norleucinal) | Recent Studies (post-2010) (acetylleucyl-leucyl-norleucinal) | Studies (pepstatin) | Trials (pepstatin) | Recent Studies (post-2010) (pepstatin) |
|---|---|---|---|---|---|
| 321 | 0 | 53 | 696 | 0 | 125 |
| Protein | Taxonomy | acetylleucyl-leucyl-norleucinal (IC50) | pepstatin (IC50) |
|---|---|---|---|
| Pepsin A | Sus scrofa (pig) | 0.011 | |
| Renin | Homo sapiens (human) | 1.9333 | |
| Cathepsin D | Homo sapiens (human) | 0.3597 | |
| Procathepsin L | Homo sapiens (human) | 0.8 | |
| Cathepsin B | Homo sapiens (human) | 4.26 | |
| Candidapepsin-2 | Candida albicans | 0.09 | |
| Pepsin A-5 | Homo sapiens (human) | 0.059 | |
| Cathepsin E | Homo sapiens (human) | 0.5558 | |
| Plasmepsin-1 | Plasmodium falciparum (malaria parasite P. falciparum) | 0.0009 | |
| Plasmepsin-2 | Plasmodium falciparum (malaria parasite P. falciparum) | 0.0005 | |
| Cathepsin D | Bos taurus (cattle) | 0.0235 | |
| Disintegrin and metalloproteinase domain-containing protein 9 | Homo sapiens (human) | 0.0563 | |
| Plasmepsin 4 | Plasmodium falciparum (malaria parasite P. falciparum) | 0.0003 | |
| Cysteine protease | Leishmania donovani | 0.16 | |
| Protease | Human immunodeficiency virus 1 | 0.947 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Choi, KM; Jiang, JH; Kim, JH; Kim, TU; Kim, YM; Lee, JW; Lee, MH; Lee, S; Park, H; Piao, TG | 1 |
2 other study(ies) available for acetylleucyl-leucyl-norleucinal and pepstatin
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Prodomain processing of recombinant plasmepsin II and IV, the aspartic proteases of Plasmodium falciparum, is auto- and trans-catalytic.
Topics: Animals; Aspartic Acid Endopeptidases; Biotransformation; Catalysis; Leupeptins; Mutation; Pepstatins; Plasmodium falciparum; Protein Structure, Tertiary; Protozoan Proteins; Recombinant Fusion Proteins | 2006 |